| 000 | 00000cam 2200000zi 4500 |
| 001 | 9.965559 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20260910153938 |
|---|
| 006 | m o d f |
|---|
| 007 | cr cn |||||||| |
|---|
| 008 | 260831e202609##onc ob f000 0 eng d |
|---|
| 020 | |a9781100003825 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH164-235/2026E-PDF |
|---|
| 245 | 00|aGuidance on preparing and submitting summary reports for marketed drugs and natural health products. |
|---|
| 246 | 1 |iAt head of title: |aHealth products |
|---|
| 250 | |a[September 2026 edition]. |
|---|
| 264 | 1|a[Ottawa] : |bHealth Canada = Santé Canada, |cSeptember 2026. |
|---|
| 264 | 4|c©2026 |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aTitle from cover. |
|---|
| 500 | |aIssued also in French under title: Ligne directrice sur la préparation et la présentation des rapports de synthèse pour les drogues et les produits de santé naturels commercialisés. |
|---|
| 504 | |aIncludes bibliographical references (page 32). |
|---|
| 520 | |a"This guidance document helps market authorization holders (MAHs) and licence holders prepare and submit annual summary reports for drugs and natural health products, interim summary reports for Natural Health Products or issue-related summary reports for drugs that comply with the following: Food and Drugs Act (FDA); Food and Drug Regulations (FDR) or Natural Health Products Regulations (NHPR)"--Overview, page 1. |
|---|
| 610 | 10|aCanada. |tFood and Drugs Act. |
|---|
| 650 | 5|aNatural health products|xGovernment policy|zCanada. |
|---|
| 650 | 0|aPharmaceutical policy|zCanada. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 775 | 08|tLigne directrice sur la préparation et la présentation des rapports de synthèse pour les drogues et les produits de santé naturels commercialisés.|w(CaOODSP)9.965558 |
|---|
| 795 | |tPreparing and submitting summary reports for marketed drugs and natural health products |b[May 23, 2018 edition]|w(CaOODSP)9.856242 |
|---|
| 856 | 40|qPDF|s731 KB|uhttps://publications.gc.ca/collections/collection_2026/sc-hc/H164-235-2026-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/reports-publications/medeffect-canada/preparing-submitting-summary-reports-marketed-drugs-natural-health-products.html |
|---|
| 986 | |a260287 |
|---|